British Journal of Cancer - Table of Contents alert Volume 119 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 119, Issue 1 In this issue Editorial Review Article Article Brief Communication Correspondence Also new AOP   Editorial TGFβ shuts the door on T cells Tobias Bald & Mark J. Smyth British Journal of Cancer 2018 119 :1 - 3; June 14, 2018; 10.1038/s41416-018-0122-x   Abstract | Full Text Review Article Checkpoint blockade in the treatment of breast cancer: current status and future directions Lironne Wein, Stephen J Luen, Peter Savas, Roberto Salgado & Sherene Loi British Journal of Cancer 2018 119 :4 - 11; May 29, 2018; 10.1038/s41416-018-0126-6   Abstract | Full Text Article Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial Tingyan Shi, Rong Jiang, Jinjin Yu, Huijuan Yang, Dongsheng Tu et al. British Journal of Cancer 2018 119 :12 - 18; June 14, 2018; 10.1038/s41416-018-0036-7   Abstract | Full Text Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study Ian Chau, Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Ronnie Poon et al. British Journal of Cancer 2018 119 :19 - 26; May 29, 2018; 10.1038/s41416-018-0103-0   Abstract | Full Text Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial Alison C. Backen, Andre Lopes, Harpreet Wasan, Daniel H Palmer, Marian Duggan et al. British Journal of Cancer 2018 119 :27 - 35; June 21, 2018; 10.1038/s41416-018-0132-8   Abstract | Full Text Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ Louisa Lisa Lo, Roger Laughlin Milne, Yuyan Liao, Jack Cuzick, Mary Beth Terry et al. British Journal of Cancer 2018 119 :36 - 39; June 21, 2018; 10.1038/s41416-018-0120-z   Abstract | Full Text The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores Ross D Dolan, Stephen T McSorley, James H Park, David G Watt, Campbell S Roxburgh et al. British Journal of Cancer 2018 119 :40 - 51; May 23, 2018; 10.1038/s41416-018-0095-9   Abstract | Full Text G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS Venugopalan Cheriyath, Jaspreet Kaur, Anne Davenport, Ashjan Khalel, Nobel Chowdhury et al. British Journal of Cancer 2018 119 :52 - 64; June 14, 2018; 10.1038/s41416-018-0137-3   Abstract | Full Text Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma Duo Xu, Shun-Qing Liang, Haitang Yang, Ursina Lüthi, Carsten Riether et al. British Journal of Cancer 2018 119 :65 - 75; June 20, 2018; 10.1038/s41416-018-0145-3   Abstract | Full Text Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers Séverine Guiu, Caroline Mollevi, Céline Charon-Barra, Florence Boissière, Evelyne Crapez et al. British Journal of Cancer 2018 119 :76 - 79; June 08, 2018; 10.1038/s41416-018-0142-6   Abstract | Full Text Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma Chao-Qun Liu, Jing Xu, Zhong-Guo Zhou, Li-Lian Jin, Xing-Juan Yu et al. British Journal of Cancer 2018 119 :80 - 88; June 20, 2018; 10.1038/s41416-018-0144-4   Abstract | Full Text Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma Anna Kaisa Kylmä, Lauri Jouhi, Dyah Listyarifah, Hesham Mohamed, Antti Mäkitie et al. British Journal of Cancer 2018 119 :89 - 95; June 22, 2018; 10.1038/s41416-018-0143-5   Abstract | Full Text Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease Martina Mijuskovic, Edward J. Saunders, Daniel A. Leongamornlert, Sarah Wakerell, Ian Whitmore et al. British Journal of Cancer 2018 119 :96 - 104; June 19, 2018; 10.1038/s41416-018-0141-7   Abstract | Full Text Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies Clément Vialatte de Pémille, Giulia Berzero, Mathilde Small, Dimitri Psimaras, Marine Giry et al. British Journal of Cancer 2018 119 :105 - 113; June 14, 2018; 10.1038/s41416-018-0125-7   Abstract | Full Text Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies Kirstin Pirie, Valerie Beral, Alicia K. Heath, Jane Green, Gillian K. Reeves et al. British Journal of Cancer 2018 119 :114 - 120; June 14, 2018; 10.1038/s41416-018-0105-y   Abstract | Full Text Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group Marloes G. M. Derks, Esther Bastiaannet, Mandy Kiderlen, Denise E. Hilling, Petra G. Boelens et al. British Journal of Cancer 2018 119 :121 - 129; June 07, 2018; 10.1038/s41416-018-0090-1   Abstract | Full Text Brief Communication Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort Rui Zheng, Mulong Du, Baoguo Zhang, Junyi Xin, Haiyan Chu et al. British Journal of Cancer 2018 119 :130 - 132; June 06, 2018; 10.1038/s41416-018-0121-y   Abstract | Full Text Correspondence Comment on “How the evolution of multicellularity set the stage for cancer” Pascal Jézéquel & Mario Campone British Journal of Cancer 2018 119 :133 - 134; May 14, 2018; 10.1038/s41416-018-0091-0   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.